Skip to search formSkip to main contentSkip to account menu

Atovaquone

Known as: 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone 
A synthetic hydroxynaphthoquinone with antiprotozoal activity. Atovoquone blocks the mitochondrial electron transport at complex III of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Atovaquone, a substituted hydroxynaphthoquinone, is a potent antimalarial drug that acts by inhibiting the parasite’s… 
Review
2006
Review
2006
The mitochondrion of Plasmodium species is a validated drug target. However, very little is known about the functions of this… 
Review
2002
Review
2002
Atovaquone is a unique naphthoquinone with broad-spectrum antiprotozoal activity. It is effective for the treatment and… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND Babesiosis is a tick-borne, malaria-like illness known to be enzootic in southern New England. A course of clindamycin… 
Highly Cited
1997
Highly Cited
1997
Continual exposure of malarial parasite populations to different drugs may have selected not only for resistance to individual… 
Highly Cited
1995
Highly Cited
1995
A series of Plasmodium falciparum in vitro drug sensitivity studies were conducted in order to evaluate atovaquone in combination… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND Both trimethoprim-sulfamethoxazole and pentamidine are effective as treatments for Pneumocystis carinii pneumonia, but…